PERCEPTIVE ADVISORS LLC Q4 2025 Filing
Filed February 17, 2026
Portfolio Value
$5.6B
Holdings
116
Report Date
Q4 2025
Filing Type
13F-HR
All Holdings (116 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | OMOUTSET MED INC | 833,333 | $3.1B | 55.10% | |
| 102 | SABSSAB BIOTHERAPEUTICS INC | 803,210 | $3.0B | 53.54% | |
| 103 | AVTXAVALO THERAPEUTICS INC | 139,667 | $2.5B | 45.20% | |
| 104 | CNTBCONNECT BIOPHARMA HLDGS LTD | 792,696 | $2.2B | 39.84% | |
| 105 | IMMXIMMIX BIOPHARMA INC | 338,941 | $1.8B | 31.58% | |
| 106 | LXEOLEXEO THERAPEUTICS INC | 139,835 | $1.4B | 24.74% | |
| 107 | CPIXCUMBERLAND PHARMACEUTICALS I | 341,087 | $1.4B | 24.19% | |
| 108 | MDLNMEDLINE INC | 28,000 | $1.2B | 20.96% | |
| 109 | PTNPALATIN TECHNOLOGIES INC | 70,000 | $1.1B | 19.18% | |
| 110 | LENZLENZ THERAPEUTICS INC | 50,000 | $800.0M | 14.26% | |
| 111 | BDSXBIODESIX | 108,694 | $739.0M | 13.17% | |
| 112 | NVNOENVVENO MEDICAL CORPORATION | 1,759,035 | $564.0M | 10.05% | |
| 113 | IOVAIOVANCE BIOTHERAPEUTICS INC | 152,714 | $416.0M | 7.41% | |
| 114 | RVMDWREVOLUTION MEDICINES INC | 250,000 | $234.0M | 4.17% | |
| 115 | ENSCENSYSCE BIOSCIENCES INC | 86,666 | $79.0M | 1.41% | |
| 116 | SRZNWSURROZEN INC | 166,666 | $3.0M | 0.05% |
PreviousPage 2 of 2